Latest news with #JimBuck
Yahoo
15-05-2025
- Business
- Yahoo
JIM BUCK OF MEDCURA, INC. NAMED EY US ENTREPRENEUR OF THE YEAR® 2025 MID-ATLANTIC AWARD FINALIST
Entrepreneur Of The Year celebrates ambitious entrepreneurs who are shaping the future COLLEGE PARK, Md., May 15, 2025 /PRNewswire/ -- Medcura, Inc. today announced that President, CEO & Director Jim Buck, MBA is an Ernst & Young LLP (EY US) finalist for the prestigious Entrepreneur Of The Year 2025 Mid-Atlantic Award. Now in its 40th year, the Entrepreneur Of The Year program honors the bold leaders who disrupt markets through the world's most ground-breaking companies, revolutionizing industries and making a profound impact on communities. The program highlights intrepid entrepreneurs whose innovations shape the future and pave the way for a thriving economy and a hopeful tomorrow. The Mid-Atlantic program celebrates entrepreneurs from Maryland, Virginia and Washington, DC. An independent panel of judges selected Buck as a finalist for his entrepreneurial spirit, transformational ingenuity, and lasting impact in building long-term value. Buck has a proven track record of innovation and entrepreneurship, having led the development and commercialization of multiple medical device technologies — including an interventional implantable cardioverter defibrillator, a minimally invasive device for mitral valve repair, portable MRI systems for intraoperative margin assessment, and synthetic polymer biosurgery technologies. At Medcura, Buck leads the development and commercialization of innovative hemostasis solutions that deploy patented biopolymer technologies to control surgical bleeding. LifeGel™, Medcura's lead product for controlling bleeding in spine surgery, is the first and only absorbable hemostatic gel to receive FDA Breakthrough Device Designation. "LifeGel is just the beginning," says Buck. "The same biopolymer powering LifeGel has far-reaching potential across surgical applications. Our development pipeline includes additional indications and new delivery formats—bellows applicators, films, powders, and textiles — each designed to offer safer, more effective, and cost-efficient bleeding control for surgeons and trauma teams." Entrepreneur Of The Year honors business leaders for their ingenuity, courage and entrepreneurial spirit. The program celebrates original founders who bootstrapped their business from inception or who raised outside capital to grow their company; transformational CEOs who infused innovation into an existing organization to catapult its trajectory. Regional award winners will be announced on June 18 during a special celebration in Washington, DC, and will become lifetime members of an esteemed community of Entrepreneur Of The Year alumni from around the world. The winners will then be considered by the National judges for the Entrepreneur Of The Year National Awards, which will be presented in November at the annual Strategic Growth Forum®, one of the nation's most prestigious gatherings of high-growth, market-leading companies. About MedcuraMedcura, Inc. is a commercial-stage medical device company developing versatile hemostatic products serving large surgical, medical, and consumer market opportunities. The Company's proprietary technology platform combines the use of safe, inert ingredients with patented chemistries, all aimed at introducing disruptively lower cost products capable of safely and effectively controlling bleeding across a broad spectrum of clinical applications. Medcura has received FDA Breakthrough Device Designations for LifeGel™, which controls surgical bleeding for spine surgeries, and LifeFoam™, a hemostatic agent for traumatic wounds. Learn more about Medcura's growing product line at About EYEY is building a better working world by creating new value for clients, people, society and the planet, while building trust in capital markets. For more information about our organization, please visit Disclaimer: LifeGel and its application tips are currently in development. All marketing claims, intended uses, and/or indications for use for this medical device and its application tips have not been cleared or approved by the FDA. Media ContactSteven FordSr. VP of Marketing & Business Developmentsford@ 466-6530 View original content to download multimedia: SOURCE Medcura Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
15-05-2025
- Business
- Yahoo
JIM BUCK OF MEDCURA, INC. NAMED EY US ENTREPRENEUR OF THE YEAR® 2025 MID-ATLANTIC AWARD FINALIST
Entrepreneur Of The Year celebrates ambitious entrepreneurs who are shaping the future COLLEGE PARK, Md., May 15, 2025 /PRNewswire/ -- Medcura, Inc. today announced that President, CEO & Director Jim Buck, MBA is an Ernst & Young LLP (EY US) finalist for the prestigious Entrepreneur Of The Year 2025 Mid-Atlantic Award. Now in its 40th year, the Entrepreneur Of The Year program honors the bold leaders who disrupt markets through the world's most ground-breaking companies, revolutionizing industries and making a profound impact on communities. The program highlights intrepid entrepreneurs whose innovations shape the future and pave the way for a thriving economy and a hopeful tomorrow. The Mid-Atlantic program celebrates entrepreneurs from Maryland, Virginia and Washington, DC. An independent panel of judges selected Buck as a finalist for his entrepreneurial spirit, transformational ingenuity, and lasting impact in building long-term value. Buck has a proven track record of innovation and entrepreneurship, having led the development and commercialization of multiple medical device technologies — including an interventional implantable cardioverter defibrillator, a minimally invasive device for mitral valve repair, portable MRI systems for intraoperative margin assessment, and synthetic polymer biosurgery technologies. At Medcura, Buck leads the development and commercialization of innovative hemostasis solutions that deploy patented biopolymer technologies to control surgical bleeding. LifeGel™, Medcura's lead product for controlling bleeding in spine surgery, is the first and only absorbable hemostatic gel to receive FDA Breakthrough Device Designation. "LifeGel is just the beginning," says Buck. "The same biopolymer powering LifeGel has far-reaching potential across surgical applications. Our development pipeline includes additional indications and new delivery formats—bellows applicators, films, powders, and textiles — each designed to offer safer, more effective, and cost-efficient bleeding control for surgeons and trauma teams." Entrepreneur Of The Year honors business leaders for their ingenuity, courage and entrepreneurial spirit. The program celebrates original founders who bootstrapped their business from inception or who raised outside capital to grow their company; transformational CEOs who infused innovation into an existing organization to catapult its trajectory. Regional award winners will be announced on June 18 during a special celebration in Washington, DC, and will become lifetime members of an esteemed community of Entrepreneur Of The Year alumni from around the world. The winners will then be considered by the National judges for the Entrepreneur Of The Year National Awards, which will be presented in November at the annual Strategic Growth Forum®, one of the nation's most prestigious gatherings of high-growth, market-leading companies. About MedcuraMedcura, Inc. is a commercial-stage medical device company developing versatile hemostatic products serving large surgical, medical, and consumer market opportunities. The Company's proprietary technology platform combines the use of safe, inert ingredients with patented chemistries, all aimed at introducing disruptively lower cost products capable of safely and effectively controlling bleeding across a broad spectrum of clinical applications. Medcura has received FDA Breakthrough Device Designations for LifeGel™, which controls surgical bleeding for spine surgeries, and LifeFoam™, a hemostatic agent for traumatic wounds. Learn more about Medcura's growing product line at About EYEY is building a better working world by creating new value for clients, people, society and the planet, while building trust in capital markets. For more information about our organization, please visit Disclaimer: LifeGel and its application tips are currently in development. All marketing claims, intended uses, and/or indications for use for this medical device and its application tips have not been cleared or approved by the FDA. Media ContactSteven FordSr. VP of Marketing & Business Developmentsford@ 466-6530 View original content to download multimedia: SOURCE Medcura
Yahoo
17-02-2025
- Politics
- Yahoo
Indiana natural gas bill would redefine the fossil fuel as green energy
Natural gas and propane — long considered contributors to climate change — could soon be redefined in Indiana as lawmakers push to lump the gasses in with solar, wind and other non-fossil fuels so they also qualify for state and federal green energy funding. Sen. Jim Buck, R-Kokomo, introduced Senate Bill 178 that, if passed, will allow natural gas and propane the same status as renewable energy sources when applying federal money to clean or green energy projects. The bill passed committee and is waiting for a vote on the Senate floor. Natural gas is a euphemism given to methane and is a 'powerful greenhouse gas,' according to NASA. The gas is more powerful than carbon dioxide when it's released and traps heat in the Earth's atmosphere. Burning methane produces less carbon dioxide than coal, but a report from the International Energy Agency says the gas is responsible for about 30% of the rise in global temperatures since the late 1700s. Indiana law currently defines methane as a clean source of energy only when it is replacing coal for power generation. Buck's bill would expand that definition to include all uses of methane and propane. Gabe Filippelli, executive director of the Environmental Resilience Institute and professor of earth sciences at Indiana University, called the attempt to redefine methane as a clean energy 'bogus.' 'They already won one battle by calling it natural gas when it's fossil gas, it's methane,' Filippelli said. 'I'm not going to gladly let them win another PR assault on common sense.' Buck said he fashioned his bill after an Ohio law that similarly defined methane as clean energy. The Ohio bill redefining methane as clean was allegedly backed by The Empowerment Alliance, a dark money group with ties to the gas industry, and the anonymously funded American Legislative Exchange Council, according to a Washington Post report. Buck is on ALEC's board of directors. Propane was added to the bill as an amendment after the Indiana Propane Gas Association approached Buck about the original bill. 'I know they use propane in some trucks and other equipment, and it is classified under the EPA as clean energy,' Buck said. Propane is a fossil fuel and produces more carbon dioxide emissions than natural gas when burned, according to data from the U.S. Energy Information Administration. Manufacturing and oil lobbyists supported the bill during a committee hearing earlier in February. Maureen Ferguson, with the American Petroleum Institute, told lawmakers that 'all of the above' energy sources must be used for continuing Indiana's goals to supply reliable and affordable energy. Carbon dioxide emissions from the power sector have declined due to a switch to burning methane, she said. 'By API's calculation, the newest gas-fired generators in the U.S. are more efficient and have lower emission rates – roughly 65% below that of the average coal plant,' Ferguson said. Carlie Hopper, representing the Indiana Builders Association, said the group supported 2021 legislation that prohibited a ban on methane and sees SB178 as an extension of that legislation. Hopper echoed the all-of-the-above approach on energy sources so Hoosiers would have affordable and reliable energy. Buck's bill is written to allow federal money to flow to natural gas projects in Indiana, but Earth Charter Indiana's Shannon Anderson told lawmakers the U.S. Department of Energy, which routinely issues federal clean energy grants, excludes natural gas from its own definition of clean energy. Locally, Indiana and Michigan Power and AES also define clean energy as something that produces no climate warming greenhouse gasses, Anderson said. 'By and large, these definitions strongly undergird a desire to eliminate carbon dioxide emissions,' Anderson said. 'So, I would strongly suggest we adhere to this careful definition as well.' When methane is burned, its emissions are lower than coal, but the gas is still inadvertently leaked into the air during extraction or while it's being transported through pipelines. These leaks or releases of unburned methane are 28 times more potent than carbon dioxide for the warming potential to our planet, Filippelli said. 'Ultimately when they burn, they release CO2, which changes the climate,' Filippelli said. 'In no way, shape, or form is that anywhere near a green technology.' IndyStar's environmental reporting project is made possible through the generous support of the nonprofit Nina Mason Pulliam Charitable Trust. Karl Schneider is an IndyStar environment reporter. You can reach him at Follow him on BlueSky @ This article originally appeared on Indianapolis Star: Indiana bill attempts to redefine this fossil fuel as clean energy
